GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

CDK2 PROTAC 37   Click here for help

GtoPdb Ligand ID: 14477

Compound class: Synthetic organic
Comment: This is an orally bioavailable, heterobifunctional PROTAC class degrader of the cyclin dependent kinase 2 (CDK2) protein [1]. CDK2 binding is mediated by a PF-06873600-derived moiety. This PROTAC mediates formation of a CDK2/Cyclin E1-cereblon (CRBN E3 ligase) ternary complex that is directed for proteasomal degradation. The PROTAC approach is proposed to act on CDK2-dependent tumours (e.g. with CCNE1 gene defects), and tumours with acquired resistance to CDK4/6 inhibitor therapies.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 13
Hydrogen bond donors 4
Rotatable bonds 11
Topological polar surface area 167.42
Molecular weight 852.89
XLogP 2.09
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@]1(CCCN(C1)C2=C(C=NC(=N2)NC3=CC=C(C=C3F)S(=O)(=O)N[C@@H]4CCN(CC5CCN(CC5)C6=CC=C(C=C6F)C7CCC(=O)NC7=O)C[C@@H]4F)C(F)(F)F)O
Isomeric SMILES C1(C2=CC(F)=C(N3CCC(CN4CC[C@@H](NS(C5=CC=C(NC6=NC=C(C(F)(F)F)C(N7CCC[C@](C)(O)C7)=N6)C(F)=C5)(=O)=O)[C@@H](F)C4)CC3)C=C2)CCC(=O)NC1=O
InChI InChI=1S/C39H46F6N8O5S/c1-38(56)12-2-13-53(22-38)35-27(39(43,44)45)19-46-37(49-35)47-31-6-4-25(18-28(31)40)59(57,58)50-32-11-14-51(21-30(32)42)20-23-9-15-52(16-10-23)33-7-3-24(17-29(33)41)26-5-8-34(54)48-36(26)55/h3-4,6-7,17-19,23,26,30,32,50,56H,2,5,8-16,20-22H2,1H3,(H,46,47,49)(H,48,54,55)/t26?,30-,32+,38-/m0/s1
InChI Key MQWDHROLFNTJMK-PONYFJNFSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Collier PN, Zheng X, Ford M, Weiss M, Chen D, Li K, Growney JD, Yang A, Sathappa M, Breitkopf SB et al.. (2025)
Discovery of Selective and Orally Bioavailable Heterobifunctional Degraders of Cyclin-Dependent Kinase 2.
J Med Chem, 68 (17): 18407-18422. [PMID:40833690]